Clinical Research Excellence · Est. 2017

Your Site, Always Inspection-Ready

The Odom Group eliminates queries, prevents missed deadlines, and maintains 100% ICH-GCP compliance — so your team can focus on patients, not paperwork. Expert clinical research support and coordinator training, grounded in 25+ years of hands-on experience.

Schedule a Free Consultation
25+
Years of Experience
2017
Established
ICH-GCP
Compliant
100%
Inspection-Ready Focus

Ready to strengthen your site's research operations?

Schedule a free 30-minute discovery call — no obligation, no pressure.

Clinical research regulatory documents
25+
Years in Clinical Research
About The Odom Group

Over Two Decades of Clinical Research Expertise

I founded The Odom Group, Inc. in 2017 after more than 25 years of hands-on clinical research experience. My career began in 2000 as a Study Coordinator in bone marrow transplant research — one of the most demanding and detail-intensive environments in clinical medicine.

Over the years I have held roles as a Clinical Research Associate (CRA), Clinical Trial Manager, and Senior CRA II — gaining comprehensive insight into every phase of the clinical trial lifecycle, from study start-up through close-out. I currently contract as a Senior CRA II while running The Odom Group.

The Odom Group was founded by a clinical research professional with a BSPH and 25+ years of industry experience — bringing both academic grounding and practical expertise to every engagement.

Study Coordinator (2000) → CRA → Clinical Trial Manager → Sr. CRA II
Founded by a BSPH professional with 25+ years of experience
ICH-GCP Compliant Operations & Inspection-Ready Focus
Founder & Sr. Clinical Research Consultant

Meet Nicole Berry

Nicole Berry is a 25-year clinical research veteran who built her career from the ground up — starting at the bedside as a Study Coordinator in Bone Marrow Transplant and Hematology-Oncology, and advancing through every major role in the field: CRA, Senior CRA II, and Clinical Trial Manager. She has led Phase I–IV trials across Oncology, Hematology, and Rare Disease, managed multi-site studies at top CROs, and navigated FDA inspections without a single Form 483.

In 2017, she founded The Odom Group, Inc. to deliver that enterprise-level expertise directly to investigative sites — without the overhead of a full-time hire. She holds a BSPH from Kent State University and is a co-author of peer-reviewed research presented at the American Society of Hematology.

Areas of Expertise

Oncology & Hematology
Leukemia, ALS, Multiple Myeloma, Hodgkin's Lymphoma, Ovarian Cancer, NSCLC
Regulatory & Compliance
ICH-GCP, FDA 21 CFR, IRB submissions, SAE reporting, audit readiness
Site Monitoring
SQV, SIV, IMV, COV — on-site and remote across Phase 1–4 trials
Trial Master File
ISF/TMF organization, eTMF platforms including Veeva Vault
Clinical Project Management
CRO oversight, vendor management, budget tracking, CRA mentoring
EDC & Data Management
CRF review, query generation & resolution, source document verification

A Career Built at the Site Level

Nicole's career started where clinical research actually happens — at the bedside. Her early years as a Study Coordinator in Bone Marrow Transplant and Hematology-Oncology gave her something most consultants lack: a firsthand understanding of the daily pressures sites face and what it takes to stay compliant under scrutiny.

Over the next two decades she advanced through every major role — CRA, Senior CRA II, Clinical Trial Manager — managing multi-site Phase I–IV studies, overseeing CRO operations, mentoring junior monitors, and steering sites through FDA inspections. She knows the work from every angle because she has done it at every level.

Today, The Odom Group partners with investigative sites across the country to resolve data backlogs, achieve audit readiness, and train the next generation of clinical research professionals — bringing enterprise-level rigor without the cost of a full-time hire.

25+ Years ExperiencePhase I–IVOncology & HematologyFounded 2017BSPH
Published Research — 45th American Society of Hematology Annual Meeting (2003)
Thrombotic Thrombocytopenic Purpura (TTP) After Allogeneic Hematopoietic Stem Cell Transplantation. Sobecks R., Rybicki L., Kalaycio M., et al. — Bone Marrow Transplant Program, The Cleveland Clinic Foundation.
The People Behind the Work

Our Team

Every engagement is led by professionals who have held the same roles as the sites we serve.

NB
Founder & Principal Consultant

Nicole Berry, BSPH

+1 more

Founder of The Odom Group, Inc. since 2017, Nicole brings 25+ years of clinical research expertise — from Study Coordinator in bone marrow transplant research to Senior CRA II and Clinical Trial Manager. She has led Phase I–IV trials across Oncology, Hematology, and Rare Disease, and now directs client strategy, quality oversight, and every engagement the firm takes on.

“Sites don't fail inspections because they don't care — they fail because no one gave them the right structure. That's exactly what we fix.”
25+ Years ExperienceBSPH — Kent State UniversityPhase I–IVOncology & HematologyRare DiseaseFounded 2017
PT
Operating Partner

Pamela Trawick

With 30+ years spanning major pharmaceutical organizations, Pamela is the operational backbone of The Odom Group. Her expertise in clinical operations, site management, and regulatory compliance ensures every client engagement is delivered with precision, accountability, and audit-ready standards.

“Compliance isn't a checklist — it's a culture. My job is to help sites build that culture from the inside out.”
30+ Years ExperienceClinical OperationsSite ManagementRegulatory CompliancePharmaceutical Industry
CR
Trainer & Contractor CRA

Carnell Reed Jr., BA

+3 more

A certified CRA with 28 years of field monitoring experience at PAREXEL, Quintiles, Baxter, and Novo Nordisk, Carnell has overseen Phase I–IV trials across seven therapeutic areas. He delivers hands-on site training in GCP compliance, EDC data entry, and regulatory file management — equipping study teams to perform at an audit-ready standard from day one.

“Good monitoring isn't about catching mistakes — it's about building the habits that prevent them.”
28 Years ExperienceCertified CRABA Biology/Chemistry — North Park UniversityMS Molecular Biology (Pending) — NEIUPhase I–IVOncology & CardiovascularCNS & NephrologyPAREXEL / Quintiles
MJ
Contractor CRA

Miya Johnson, BS, MBA

+4 more

Miya is a Senior CRA whose decade-long career spans Novo Nordisk, PPD, PAREXEL, PRA, and IQVIA — with Phase I–III monitoring experience across eight therapeutic areas. Her background in risk-based site management and healthcare administration brings both clinical rigor and strategic perspective to every site she supports.

“Every site has unique pressures. My role is to understand those pressures and turn them into a plan that actually works in the real world.”
10+ Years ExperienceBS — Grambling State UniversityMBA Healthcare Admin — FITPhase I–IIIOncology & EndocrinologyWomen's Health & Rare DiseaseNovo Nordisk / PPD / IQVIA

The Odom Group also works with a vetted network of senior clinical research contractors — all operating under the same standards of compliance, confidentiality, and professionalism that define our firm.

Clinical Research Support

Comprehensive Site Support Services

Our team works collaboratively with sites, sponsors, and CROs to ensure documentation accuracy, compliance with ICH-GCP guidelines, and overall operational efficiency throughout the trial lifecycle.

Study coordinator at work

Stay Inspection-Ready, Always

My flexible support model allows investigators and coordinators to focus on patient care and study execution while I ensure your documentation and regulatory files are always audit-ready. I understand the operational challenges many sites face — particularly related to regulatory documentation, TMF/ISF maintenance, study start-up preparation, and ongoing study management.

ISF/TMFICH-GCPVeeva VaultEDCRemote Support

Regulatory Document Management

Comprehensive ISF/TMF organization and maintenance to ensure constant inspection readiness.

Study Start-Up Assistance

Expert preparation of essential documents to accelerate site activation and first patient enrollment.

eTMF & Veeva Vault Support

Proficient management of electronic Trial Master Files across leading platforms.

Monitoring Visit Preparation

Ensuring sites are fully prepared for CRA visits and assisting with action item resolution.

Source Document Review & QC

Rigorous review processes to maintain data integrity and protocol compliance.

5-Day Guarantee

Data Entry & EDC Support

Timely and accurate electronic data capture management across major EDC platforms — guaranteed within 5 business days of each subject visit, meeting sponsor and CRO deadlines every time.

Stay query-free & inspection-ready

Study Close-Out Preparation

Thorough document reconciliation and archiving support for seamless trial closure.

Remote Research Coordination

Flexible, off-site assistance to augment your existing research team on demand.

Signature Service Guarantee

5 Business Day EDC Data Entry — Guaranteed

Sponsors and CROs require data to be entered into the EDC within 5 business days of a subject visit. Missing this deadline generates queries, triggers monitoring findings, and puts your site at risk of increased oversight. I provide timely, accurate data entry so your site stays query-free, compliant, and inspection-ready — every time.

No missed deadlines
Query-free records
Inspection-ready data
All major EDC platforms
Tell Us About Your Site

No commitment required — we will review your site's situation and respond within one business day.

Study Coordinator Training Program

A Curriculum Built From the Trenches of Clinical Research

I have spent 25+ years in every role a clinical research professional can hold — Study Coordinator, CRA, Clinical Trial Manager, and Senior CRA II. This training program translates that real-world experience into practical, inspection-ready knowledge for new and advancing Study Coordinators. Click any module below to see exactly what is covered and what you will be able to do after completing it.

Clinical research training session

Program Highlights

8 comprehensive modules
Real-world case examples from 25+ years of practice
Regulatory frameworks: FDA 21 CFR, ICH-GCP E6(R2)
Hands-on document and EDC exercises
Available in-person, virtual, or hybrid format
Group and individual sessions available

Who Should Attend?

New and entry-level Study Coordinators
Experienced coordinators seeking to upskill
Research staff transitioning from clinical roles
Sites preparing for regulatory inspections
CRO and sponsor staff supporting sites
Training Investment

Study Coordinator Training Pricing

All training is priced per person. Virtual sessions are delivered live via Zoom — link provided upon booking. In-person and hybrid formats are also available, scheduled around your availability.

Single Module
$175per person

Perfect for targeted skill-building on one specific topic area.

  • One module of your choice
  • ~2–3 hours of instruction
  • Real-world case examples
  • Q&A with Nicole Berry
  • Available virtual or in-person
Most Popular
Full Program
$1,299per person

The complete 8-module curriculum — everything a Study Coordinator needs to excel.

  • All 8 modules (16–24 hrs total)
  • Delivered over 8 sessions
  • FDA 21 CFR & ICH-GCP E6(R2)
  • Hands-on document & EDC exercises
  • In-person, virtual, or hybrid
  • Certificate of completion
Small Group
$699per person (up to 5)

Same full 8-module curriculum, delivered to a small group — ideal for site teams.

  • All 8 modules for up to 5 people
  • Group total from $3,495
  • Coordinated scheduling
  • Group Q&A and discussion
  • In-person, virtual, or hybrid
  • Certificate of completion
Site-Wide & Corporate Training

Training your entire research site? The Odom Group offers custom site-wide engagements for investigative sites, CROs, and sponsor organizations — tailored to your protocols, SOPs, and regulatory environment. Pricing is scoped to your site size, format, and curriculum needs.

Clinical Research Support Services

Support Services Are Custom-Quoted

Clinical research support engagements vary significantly based on scope, trial phase, site needs, and duration. The Odom Group offers flexible arrangements — hourly consulting, monthly retainers, and project-based engagements — all tailored to your specific situation. Reach out to discuss your site's needs and receive a custom proposal.

Hourly Consulting
Ad-hoc support, document review, QC, and regulatory guidance
Monthly Retainer
Ongoing ISF/TMF maintenance, monitoring prep, and site support
Project-Based
Study start-up, close-out, or specific milestone deliverables
For Investigative Sites

Partnering with Sites, Sponsors & CROs

I understand the operational challenges many sites face firsthand. My flexible support model is designed to integrate seamlessly with your existing staff.

Regulatory Compliance

I ensure documentation accuracy and compliance with ICH-GCP guidelines across all phases of your trial.

Operational Efficiency

My support reduces administrative burden on your clinical staff, allowing focus on patient care and study execution.

Inspection Readiness

I maintain your site in a state of continuous inspection readiness — no scrambling before an audit.

The Smart Choice

Why Choose The Odom Group?

See how partnering with The Odom Group compares to hiring a full-time staff member or relying on an already-stretched coordinator team.

FactorFull-Time Hire / In-House Staff✓ The Odom Group, Inc.
Cost$60,000–$90,000/yr salary + benefits + overheadFlexible hourly, retainer, or project-based — pay only for what you need
AvailabilityFixed schedule; gaps during leave, turnover, or hiring delaysOn-demand support — scale up or down based on study activity
ExpertiseVaries by individual; may require additional training25+ years of hands-on CRA, CTM, and coordinator experience across multiple TAs
Regulatory KnowledgeDependent on staff experience and training budgetDeep ICH-GCP, FDA, and sponsor-specific regulatory expertise built in
EDC Data EntryDependent on coordinator workload and competing prioritiesGuaranteed within 5 business days of each subject visit — every time
Inspection ReadinessReactive — often scrambling before auditsProactive, continuous — your site is always audit-ready
Onboarding TimeWeeks to months for hiring, onboarding, and trainingRapid deployment — our team integrates with your site quickly
CommitmentLong-term employment contractNo long-term contracts — flexible engagement terms

Ready to see the difference? Schedule a free 30-minute discovery call.

Portfolio & Expertise

25+ Years of Clinical Research Experience

From first-in-human oncology trials to large-scale Phase III pivotal studies, my portfolio spans every phase of the clinical trial lifecycle across six therapeutic areas. Every engagement is backed by deep regulatory expertise and a commitment to data quality.

🔬

Oncology & Hematology

Bone marrow transplant, leukemia, lymphoma, and solid tumor trials across Phase I–III. Includes CAR-T cell therapy and targeted oncology agents.

Phase I, II, III
❤️

Cardiovascular

Lipid management, heart failure, and anticoagulation studies. Experience with cardiac endpoint adjudication and complex ECG monitoring requirements.

Phase II, III
🧬

Infectious Disease

Antiviral, antibacterial, and vaccine trials including HIV and respiratory disease programs with complex eligibility criteria and safety monitoring.

Phase II, III, IV
🧠

Neurology & CNS

Alzheimer's disease, multiple sclerosis, and psychiatric disorder studies. Experience with cognitive assessments, patient-reported outcomes, and long-term follow-up.

Phase II, III
⚗️

Endocrinology & Metabolic

Type 2 diabetes, obesity, and thyroid disorder programs. Includes continuous glucose monitoring protocols and complex laboratory panel requirements.

Phase II, III
🌿

Rare & Orphan Diseases

Small patient population studies with expanded access protocols, compassionate use programs, and heightened regulatory documentation requirements.

Phase I, II, III

Signature Service Guarantee

5 Business Day EDC Data Entry — Guaranteed

Sponsors and CROs require data to be entered into the EDC within 5 business days of a subject visit. Missing this deadline generates queries, triggers monitoring findings, and puts your site at risk of increased oversight. I provide timely, accurate data entry so your site stays query-free, compliant, and inspection-ready — every time.

Monthly Newsletter

The Research Roundup

Practical regulatory tips, industry updates, and real-world guidance from 25+ years in clinical research — delivered free to your inbox every month.

Issue No. 01 · April 2026Regulatory

5 ISF Findings That Trigger a Repeat Monitoring Visit — And How to Avoid Them

After 25+ years in clinical research, I've seen the same documentation gaps come up again and again. The ISF is the backbone of your site's regulatory compliance — here are the five findings that put sites on a monitor's watch list.

6 min read
Coming · May 2026Training

What New Study Coordinators Wish They Knew in Their First 90 Days

The first three months in a coordinator role are the most overwhelming — and the most formative. I'll share the practical knowledge that takes most coordinators years to learn on their own.

Coming soonSubscribe to read
Coming · June 2026EDC & Data

The Top 5 ICF Errors That Put Your Site at Risk

Informed consent errors are among the most common — and most preventable — protocol deviations. A single wrong version or missing re-consent can invalidate a subject's entire data record.

Coming soonSubscribe to read

Free Monthly Newsletter

Get The Research Roundup in Your Inbox

Every month I share practical regulatory tips, industry updates, training insights, and real-world guidance from 25+ years in clinical research. Join coordinators, site directors, and research professionals who read it every month.

Regulatory TipsIndustry NewsTraining InsightsNo Spam

Monthly. No spam. Unsubscribe anytime.

Results That Speak for Themselves

Case Studies

Real-world engagements with measurable outcomes. All client details are anonymized.

📊
EDC & Data Entry

Cleared a 3-Month EDC Backlog in 14 Days

14 days to full resolution0 violations post-engagementWarning letter closed
Situation

A Phase III oncology site was 90+ days behind on EDC entry after losing two coordinators mid-study. The sponsor had issued a formal warning letter citing repeated 5-business-day deadline violations.

Approach

Conducted a full data gap analysis, prioritized entries by visit date and query risk, and worked systematically through the backlog using the site's existing source documents — all remotely.

Outcome

100% of outstanding data entered within 14 calendar days. Zero new deadline violations in the 6 months following engagement. Sponsor warning letter formally closed.

📁
ISF / TMF Support

Prepared a Site for FDA Inspection in 3 Weeks

3 weeks to inspection-ready0 Form 483 observationsFull ISF gap closed
Situation

A community research site received a 30-day FDA inspection notice for an active oncology study. Their ISF had not been formally maintained in over a year — missing regulatory documents, outdated delegation logs, and incomplete consent tracking.

Approach

Performed a full ISF gap assessment against the protocol and sponsor requirements, organized all existing documents, identified and collected missing items, and built a document tracker the site could maintain independently going forward.

Outcome

Site passed the FDA inspection with zero Form 483 observations related to the ISF. Site director reported the inspection as the smoothest in the site's history.

🎓
Study Coordinator Training

New Coordinator Running Independent Visits in 6 Weeks

6 weeks to independent visits0 training-related findingsRepeat engagement requested
Situation

A Phase II cardiology site hired a nurse with no clinical research experience as their sole study coordinator. The PI needed her running independent visits within 60 days to maintain study timelines.

Approach

Delivered a customized 6-week training program covering GCP fundamentals, protocol review, source documentation, ICF procedures, EDC entry, and monitoring visit preparation — tailored to the specific study and site SOPs.

Outcome

Coordinator passed her first monitoring visit with no training-related findings. Site maintained enrollment timelines. PI requested a second training engagement for an incoming coordinator the following quarter.

Ready to see results like these at your site?

Schedule a Free Consultation
What People Are Saying

Trusted by Sites & Coordinators

✦ Placeholder testimonials — to be updated with real client feedback

Nicole's training gave our new coordinator the confidence and regulatory knowledge she needed from day one. The module on ISF maintenance alone saved us from a major finding during our next monitoring visit.

SM
Dr. Sarah M.
Principal Investigator · Academic Medical Center

We brought Nicole in to help us prepare for a sponsor audit and she had our TMF organized and inspection-ready within two weeks. Her attention to detail and knowledge of ICH-GCP is exceptional.

RT
Rachel T.
Research Site Director · Community Research Site

The full 8-module program was exactly what I needed to transition from a clinical nursing role into research coordination. Nicole explains complex regulatory concepts in a way that actually makes sense.

JW
Jasmine W.
Study Coordinator · Oncology Research Program

Our site has worked with many consultants over the years, but Nicole's hands-on experience as both a coordinator and a CRA gives her a unique perspective. She understands both sides of the monitoring relationship.

MD
Mark D.
Clinical Operations Manager · Phase II–III Research Site
Frequently Asked Questions

Got Questions? We Have Answers.

Here are the questions I hear most often from sites, coordinators, and sponsors. Don't see yours? Reach out directly.

Get In Touch
Nicole Berry
Founder & Sr. Clinical Research Consultant
The Odom Group, Inc.

Let's Discuss How I Can Support Your Site

Whether you're an investigative site looking for operational support, a coordinator seeking training, or a sponsor/CRO exploring partnership opportunities — I'd love the chance to connect. Please reach out to schedule a brief introductory call.

Location
United States (Remote & On-Site)
Schedule a Free Consultation

Pick a time that works for you — no phone tag required.

Send a Message